Buscar resultados de ensayos clínicos
Cholangitis - 62 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2012-09-10 Intervenciones:
|
| Completed |
Nombre del estudio: Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis Condición: Cholangitis, Sclerosing Fecha: 2000-02-24 Intervenciones: Drug: cladribine |
| Completed |
Nombre del estudio: Probiotics in Patients With Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2005-09-08 Intervenciones: Drug: Probiotics |
| Active, not recruiting |
Nombre del estudio: Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects Condición: Primary Sclerosing Cholangitis Fecha: 2013-02-21 Intervenciones: Drug: Oral Vancomycin Other Name: Vancocin |
| Completed |
Nombre del estudio: Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients Condición: Primary Sclerosing Cholangitis Fecha: 2015-10-31 Intervenciones:
|
| Completed |
Nombre del estudio: A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2010-03-10 Intervenciones:
|
| Completed |
Nombre del estudio: A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2016-11-22 Intervenciones: Drug: Curcumin Subjects will receive one 750 mg softgel by mouth twice a day for 12 weeks. Each each 750 |
| Completed |
Nombre del estudio: Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2012-12-19 Intervenciones:
|
| Active, not recruiting |
Nombre del estudio: Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2016-02-29 Intervenciones:
|
| Completed |
Nombre del estudio: MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension) Condición: Primary Biliary Cirrhosis Fecha: 2016-11-02 Intervenciones:
|